Location History:
- Leominster, MA (US) (2015)
- Hagerstown, MD (US) (2016)
Company Filing History:
1 out of 5 
1 out of 173 
1 out of 2 Years Active: 2015-2016
Title: The Innovations of James McGivney: A Glimpse into His Patented Contributions
Introduction
James McGivney, an innovative inventor based in Leominster, MA, has made significant strides in the field of biomedicine. With a total of 2 patents to his name, McGivney’s work reflects a deep understanding of immunology and the development of novel therapeutic strategies.
Latest Patents
One of McGivney’s latest inventions is titled "Antibodies to FcRn and uses thereof." This patent encompasses proteins that bind to the neonatal Fc receptor (FcRn), specifically immunoglobulins that exhibit high affinity and selectivity in inhibiting FcRn. Such innovations hold potential therapeutic applications in treating various autoimmune disorders. The second patent, "Immunoglobulin chimeric monomer-dimer hybrids," describes a unique chimeric monomer-dimer hybrid protein composed of two polypeptide chains. The first chain integrates a portion of an immunoglobulin constant region alongside a biologically active molecule, while the second chain features a portion of the immunoglobulin constant region devoid of the biologically active component. This invention not only covers the methods of creating such hybrid proteins but also their potential applications in medical treatments.
Career Highlights
Throughout his career, James McGivney has contributed to various esteemed organizations. Notably, he has worked with Biogen Idec Hemophilia Inc., a company renowned for its advancements in hemophilia therapies. Additionally, he was associated with Dyax Corporation, further establishing his expertise in the biotech sector.
Collaborations
McGivney's journey also includes collaborations with notable colleagues. Among his coworkers are Alan J. Bitonti and Robert T. Peters, with whom he has likely shared insights and developments that propelled their collective innovations in immunology and biotechnology.
Conclusion
James McGivney stands out as a significant figure in the realm of biotechnology, with his patents promising advancements in the treatment of immune-related disorders. His dedication to innovation and collaboration has not only enriched his career but has also contributed to the broader field of medical research, paving the way for future discoveries.